China Resources Pharmaceutical Group Limited (HKG: 3320)

Market Cap	32.79B
Revenue (ttm)	269.14B
Net Income (ttm)	4.06B
Shares Out	6.28B
EPS (ttm)	0.64
PE Ratio	8.19
Forward PE	6.63
Dividend	0.17 (3.24%)
Ex-Dividend Date	Sep 10, 2024

Volume	15,915,500
Open	5.12
Previous Close	5.22
Day's Range	4.97 - 5.22
52-Week Range	4.45 - 6.40
Beta	0.39
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 29, 2024

About China Resources Pharmaceutical Group

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and v, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Employees: 72,986
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3320

Financial Performance

In 2023, China Resources Pharmaceutical Group's revenue was 244.70 billion, an increase of 12.16% compared to the previous year's 218.18 billion. Earnings were 3.85 billion, an increase of 10.11%.

Financial numbers in CNY